Regulation of cardiovascular signaling by kinins and products of similar converting enzyme systems - Upregulation of Cdc2 and cyclin A during apoptosis of endothelial cells induced by cleaved high-molecular-weight kininogen

被引:23
作者
Wang, SJ
Hasham, MG
Isordia-Salas, I
Tsygankov, AY
Colman, RW
Guo, YL
机构
[1] Temple Univ, Sol Sherry Thrombosis Res Ctr, Sch Med, Philadelphia, PA 19140 USA
[2] Temple Univ, Dept Microbiol & Immunol, Sch Med, Philadelphia, PA 19140 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2003年 / 284卷 / 06期
关键词
angiogenesis; bradykinin; cell cycle;
D O I
10.1152/ajpheart.00861.2002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We (8) reported that the cleaved high-molecular-weight kininogen (HKa) and its domain 5 (D5) inhibited angiogenesis. Further studies (15) revealed that D5 could inhibit cell proliferation and induce apoptosis of proliferating endothelial cells, which together may represent a critical part of antiangiogenic activity of HKa and D5. In the present study, we further examined the effect of HKa on cell cycle progression and cell viability. We report that HKa induced a significant upregulation of Cdc2 and cyclin A in proliferating endothelial cells, concurrent with a marked increase of Cdc2 activity. The increased expression of Cdc2 and cyclin A by HKa was not associated with an apparent change in cell cycle profiles of basic fibroblast growth factor-stimulated proliferating cells, but closely correlated with a marked increase of apoptosis, suggesting that the elevated Cdc2 activity is involved in HKa-induced apoptosis of proliferating endothelial cells. Our results support an emerging hypothesis that Cdc2 and cyclin A are important regulators for cell cycle as well as for apoptosis.
引用
收藏
页码:H1917 / H1923
页数:7
相关论文
共 32 条
[1]   Factors promoting tumor angiogenesis [J].
Beckner, ME .
CANCER INVESTIGATION, 1999, 17 (08) :594-623
[2]   The hemostatic system as a regulator of angiogenesis [J].
Browder, T ;
Folkman, J ;
Pirie-Shepherd, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :1521-1524
[3]   Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis [J].
Cao, RH ;
Wu, HL ;
Veitonmäki, N ;
Linden, P ;
Farnebo, J ;
Shi, GY ;
Cao, YH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5728-5733
[4]   Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth [J].
Cao, YH ;
Chen, A ;
An, SSA ;
Ji, RWD ;
Davidson, D ;
Cao, YM ;
Llinas, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (36) :22924-22928
[5]  
Chadebech P, 2000, INT J CANCER, V87, P779, DOI 10.1002/1097-0215(20000915)87:6<779::AID-IJC3>3.0.CO
[6]  
2-4
[7]  
Chavakis T, 2000, BLOOD, V96, P514
[8]   Cdc2 and Cdk2 kinase activated by transforming growth factor-β1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells [J].
Choi, KS ;
Eom, YW ;
Kang, Y ;
Ha, MJ ;
Rhee, H ;
Yoon, JW ;
Kim, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) :31775-31783
[9]   Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen [J].
Colman, RW ;
Pixley, RA ;
Sainz, IM ;
Song, JS ;
Isordia-Salas, I ;
Muhamed, SN ;
Powell, JA ;
Mousa, SA .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (01) :164-170
[10]   Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor [J].
Colman, RW ;
Pixley, RA ;
Najamunnisa, S ;
Yan, WY ;
Wang, JY ;
Mazar, A ;
McCrae, KR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1481-1487